| Profile | GDS5420 / 244745_at |
| Title | Psoriasis response to brodalumab: dose response and time course |
| Organism | Homo sapiens |
| Sample | Title | Value | Rank |
|---|---|---|---|
| GSM1296094 | A_lesional_pre-dose | 75.79 | 37 |
| GSM1296119 | B_lesional_pre-dose | 419.11 | 65 |
| GSM1296076 | C_lesional_pre-dose | 329.62 | 62 |
| GSM1296092 | D_lesional_pre-dose | 131.37 | 48 |
| GSM1296103 | E_lesional_pre-dose | 24.86 | 22 |
| GSM1296078 | F_lesional_pre-dose | 302.76 | 61 |
| GSM1296107 | G_lesional_pre-dose | 275.3 | 57 |
| GSM1296109 | H_lesional_pre-dose | 106.88 | 41 |
| GSM1296080 | I_lesional_pre-dose | 233.04 | 56 |
| GSM1296090 | J_lesional_pre-dose | 96.17 | 42 |
| GSM1296074 | K_lesional_pre-dose | 219.13 | 56 |
| GSM1296111 | L_lesional_pre-dose | 342.52 | 61 |
| GSM1296099 | M_lesional_pre-dose | 237.76 | 55 |
| GSM1296086 | O_lesional_pre-dose | 116.65 | 45 |
| GSM1296117 | P_lesional_pre-dose | 466.68 | 66 |
| GSM1296113 | Q_lesional_pre-dose | 415.36 | 64 |
| GSM1296096 | R_lesional_pre-dose | 111.25 | 44 |
| GSM1296105 | S_lesional_pre-dose | 586.39 | 70 |
| GSM1296098 | T_lesional_pre-dose | 78.25 | 36 |
| GSM1296101 | U_lesional_pre-dose | 78.47 | 37 |
| GSM1296121 | V_lesional_pre-dose | 237.81 | 55 |
| GSM1296088 | W_lesional_pre-dose | 211.8 | 54 |
| GSM1296082 | X_lesional_pre-dose | 153.02 | 50 |
| GSM1296115 | Y_lesional_pre-dose | 228.07 | 54 |
| GSM1296084 | Z_lesional_pre-dose | 275.11 | 58 |
| GSM1296072 | B_lesional_day8 | 565.81 | 70 |
| GSM1296069 | L_lesional_day8 | 486.45 | 67 |
| GSM1296071 | P_lesional_day8 | 722.24 | 74 |
| GSM1296070 | Y_lesional_day8 | 456.85 | 66 |
| GSM1296073 | V_lesional_day8 | 172.9 | 50 |
| GSM1296034 | A_lesional_day15 | 47.06 | 29 |
| GSM1296041 | G_lesional_day15 | 248.63 | 56 |
| GSM1296035 | R_lesional_day15 | 91.36 | 41 |
| GSM1296038 | U_lesional_day15 | 168.12 | 50 |
| GSM1296047 | B_lesional_day15 | 477.81 | 67 |
| GSM1296039 | E_lesional_day15 | 267.62 | 58 |
| GSM1296042 | H_lesional_day15 | 520.43 | 68 |
| GSM1296043 | L_lesional_day15 | 583.11 | 70 |
| GSM1296037 | M_lesional_day15 | 382.18 | 63 |
| GSM1296046 | P_lesional_day15 | 474.51 | 66 |
| GSM1296044 | Q_lesional_day15 | 351.37 | 61 |
| GSM1296045 | Y_lesional_day15 | 503.43 | 67 |
| GSM1296025 | C_lesional_day15 | 481.63 | 67 |
| GSM1296033 | D_lesional_day15 | 241.97 | 56 |
| GSM1296027 | I_lesional_day15 | 330.35 | 61 |
| GSM1296032 | J_lesional_day15 | 187.88 | 51 |
| GSM1296024 | K_lesional_day15 | 283.43 | 58 |
| GSM1296031 | W_lesional_day15 | 255.51 | 56 |
| GSM1296028 | X_lesional_day15 | 370.94 | 62 |
| GSM1296029 | Z_lesional_day15 | 480.6 | 67 |
| GSM1296026 | F_lesional_day15 | 458.47 | 67 |
| GSM1296030 | O_lesional_day15 | 150.55 | 50 |
| GSM1296040 | S_lesional_day15 | 158.99 | 48 |
| GSM1296036 | T_lesional_day15 | 132.47 | 45 |
| GSM1296048 | V_lesional_day15 | 206.3 | 52 |
| GSM1296059 | A_lesional_day43 | 79.58 | 39 |
| GSM1296066 | G_lesional_day43 | 513.75 | 68 |
| GSM1296060 | R_lesional_day43 | 248.15 | 56 |
| GSM1296063 | U_lesional_day43 | 201.14 | 52 |
| GSM1296064 | E_lesional_day43 | 157.29 | 49 |
| GSM1296067 | H_lesional_day43 | 611.67 | 71 |
| GSM1296062 | M_lesional_day43 | 173.99 | 50 |
| GSM1296068 | Q_lesional_day43 | 507.38 | 67 |
| GSM1296050 | C_lesional_day43 | 946.08 | 78 |
| GSM1296057 | D_lesional_day43 | 283.06 | 58 |
| GSM1296052 | I_lesional_day43 | 294.66 | 60 |
| GSM1296054 | J_lesional_day43 | 176 | 50 |
| GSM1296049 | K_lesional_day43 | 438.87 | 66 |
| GSM1296055 | W_lesional_day43 | 250.35 | 55 |
| GSM1296053 | X_lesional_day43 | 253.27 | 56 |
| GSM1296058 | Z_lesional_day43 | 89.4 | 41 |
| GSM1296051 | F_lesional_day43 | 644.98 | 72 |
| GSM1296056 | O_lesional_day43 | 100.94 | 43 |
| GSM1296065 | S_lesional_day43 | 643.44 | 72 |
| GSM1296061 | T_lesional_day43 | 59.71 | 33 |
| GSM1296095 | A_non-lesional_pre-dose | 184.06 | 51 |
| GSM1296120 | B_non-lesional_pre-dose | 414.6 | 64 |
| GSM1296077 | C_non-lesional_pre-dose | 589.1 | 71 |
| GSM1296093 | D_non-lesional_pre-dose | 324.86 | 60 |
| GSM1296104 | E_non-lesional_pre-dose | 303.28 | 59 |
| GSM1296079 | F_non-lesional_pre-dose | 920.5 | 78 |
| GSM1296108 | G_non-lesional_pre-dose | 433.09 | 65 |
| GSM1296110 | H_non-lesional_pre-dose | 381.09 | 62 |
| GSM1296081 | I_non-lesional_pre-dose | 141.82 | 48 |
| GSM1296091 | J_non-lesional_pre-dose | 103.65 | 43 |
| GSM1296075 | K_non-lesional_pre-dose | 419.5 | 66 |
| GSM1296112 | L_non-lesional_pre-dose | 640.31 | 72 |
| GSM1296100 | M_non-lesional_pre-dose | 328.5 | 60 |
| GSM1296087 | O_non-lesional_pre-dose | 256.5 | 58 |
| GSM1296118 | P_non-lesional_pre-dose | 786.99 | 75 |
| GSM1296114 | Q_non-lesional_pre-dose | 425.26 | 64 |
| GSM1296097 | R_non-lesional_pre-dose | 183.23 | 51 |
| GSM1296106 | S_non-lesional_pre-dose | 447.46 | 65 |
| GSM1296102 | U_non-lesional_pre-dose | 250.07 | 55 |
| GSM1296122 | V_non-lesional_pre-dose | 617.3 | 71 |
| GSM1296089 | W_non-lesional_pre-dose | 310.01 | 59 |
| GSM1296083 | X_non-lesional_pre-dose | 127.52 | 45 |
| GSM1296116 | Y_non-lesional_pre-dose | 740.25 | 74 |
| GSM1296085 | Z_non-lesional_pre-dose | 342.54 | 61 |